Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The therapeutic effect of ALT-711 on erectile function in rats treated with high-level AGEs (advanced glycation end products) containing diet

A Correction to this article was published on 04 March 2022

This article has been updated

Abstract

To investigate, if advanced glycation end products (AGEs) are involved in erectile dysfunction (ED) and also ALT-711, a cross-link breaker of AGEs, has the therapeutic potential against the development of ED in rats treated with high concentrated AGEs including food. For this purpose, 30 male Harlan Spraque-Dawley rats randomly were divided into three groups; (1) control rats treated with regular diet, (2) rats treated with high-level of AGE specific diet for 6 months, and (3) rats having AGE-diet treated with ALT-711 for the final 3 months of 6 months of AGE-diet period. Erectile response to cavernosal nerve stimulation (CNS), protein expression of neuronal nitric oxide synthase (nNOS) and levels of AGEs, Malondialdehyde (MDA), cyclic guanosine monophosphate (cGMP) were determined in penile tissues. Erectile responses to CNS and penile nNOS and cGMP content were significantly reduced, while AGEs and MDA were elevated in penises of Group-2. Treatment with ALT-711 reversed ED and depletion of both nNOS and cGMP. Additionally, ALT-711 treatment reduced penile tissue AGEs and MDA expression. In present study: rats without any co-morbidity such as diabetes mellitus (DM) and chronic renal failure (CRF) were treated with high-level AGEs containing food. Our results suggest that ALT-711 may be an interesting and promising approach in the treatment of AGEs-related ED.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Cavernosal advanced glycation end product (5-HMF) and MDA levels.
Fig. 2: Cavernosal cGMP levels.
Fig. 3: Cavernosal nNOS protein expression.
Fig. 4: The voltage depending erectile response.

Similar content being viewed by others

Change history

References

  1. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology. 1997;50:1016–26.

    Article  CAS  Google Scholar 

  2. Usta MF, Tuncer M, Baykal A, Ciftçioğlu MA, Erdoğru T, Köksal IT, et al. Impact of chronic renal failure fluids and peritoneal dialysis fluids on advanced glycation end product and iNOS levels in penile tissue: an experimental study. Urology. 2002;59:953–7.

    Article  CAS  Google Scholar 

  3. Gurbuz N, Kol A, Ipekci T, Ates E, Baykal A, Usta MF. Chronic administration of sildenafil improves erectile function in a rat model of chronic renal failure. Asian J Androl. 2015;17:797–801.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Gurbuz N, Sagdic G, Sanli A, Ciftcioglu A, Bassorgun I, Baykal A, et al. Therapeutic effect of combination of alagebrium (ALT-711) and sildenafil on erectile function in diabetic rats. Int J Imp Res. 2012;24:114–21.

    Article  CAS  Google Scholar 

  5. Usta MF, Bivalacqua TJ, Yang DY, Ramanitharan A, Sell DR, Viswanathan A, et al. The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. J Urol. 2003;170:1437–42.

    Article  CAS  Google Scholar 

  6. Neves D. Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction. Free Radic Res. 2013;47:49–69.

    Article  CAS  Google Scholar 

  7. Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;9:411–29.

    Article  Google Scholar 

  8. Usta MF, Kendirci M, Gur S, Foxwell NA, Bivalacqua TJ, Cellek S, et al. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. J Sex Med. 2006;3:242–52.

    Article  CAS  Google Scholar 

  9. Lin F, Gou X. Panax notoginseng saponins improve the erectile dysfunction in diabetic rats by protecting the endothelial function of the penile corpus cavernosa. Int J Imp Res. 2013;25:206–11.

    Article  CAS  Google Scholar 

  10. Neves D, Assunção M, Marques F, Andrade JP, Almeida H. Does regular consumption of green tea influence VEGF and its receptors expression in aged rat erectile tissue? Possible implications in vasculogenic erectile dysfunction progression. Age. 2008;30:217–28.

    Article  CAS  Google Scholar 

  11. Grillo MA, Colombatto S. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids. 2008;35:29–36.

    Article  CAS  Google Scholar 

  12. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Investig. 1997;99:457–68.

    Article  CAS  Google Scholar 

  13. Simm A. Protein glycation during aging and in cardiovascular disease. J Proteom. 2013;92:248–59.

    Article  CAS  Google Scholar 

  14. Kasai K, Nakamura T, Kase N, Hiraoka T, Suzuki R, Kogure F, et al. Increased glycosylation of proteins from cataractous lenses in diabetes. Diabetologia. 1983;25:36–8.

    Article  CAS  Google Scholar 

  15. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid reactive subtances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39:2522–6.

    Article  CAS  Google Scholar 

  16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.

    Article  CAS  Google Scholar 

  17. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJG. Endothelial dysfunction in erectile dysfunction: role of endothelium in erectile physiology and disease. J Androl. 2003;24:17–37.

    Article  Google Scholar 

  18. Usta MF, Bivalacqua TJ, Koksal IT, Toptas B, Surmen S, Hellstrom WJG. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment. BJU Int. 2004;94:429–32.

    Article  CAS  Google Scholar 

  19. Wang L, Tian W, Uwais Z, Li G, Li H, Guan R, et al. AGE-breaker ALT-711 plus insulin could restore erectile function in streptozotocin-induced type 1 diabetic rats. J Sex Med. 2014;11:1452–62.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Akdeniz University Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. F. Usta.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised to correct author name E. Ceylan to A. Ender Caylan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gurbuz, N., Gurkan, R., Ender Caylan, A. et al. The therapeutic effect of ALT-711 on erectile function in rats treated with high-level AGEs (advanced glycation end products) containing diet. Int J Impot Res 34, 222–228 (2022). https://doi.org/10.1038/s41443-021-00417-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41443-021-00417-8

Search

Quick links